Imperial College London-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds

    Scientific Data

2018

  1. A model-based assay design to reproduce in vivo patterns of acute drug-induced toxicity

    Archives of Toxicology

2013

  1. A combination of transcriptomics and metabolomics uncovers enhanced bile acid biosynthesis in HepG2 cells expressing CCAAT/enhancer-binding protein β (C/EBPβ), hepatocyte nuclear factor 4α (HNF4α), and constitutive androstane receptor (CAR)

    Journal of Proteome Research, Vol. 12, Núm. 6, pp. 2732-2741

2003

  1. Comparative studies on the cytochrome P450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems

    Drug Metabolism and Disposition, Vol. 31, Núm. 9, pp. 1093-1102

2002

  1. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells

    Xenobiotica, Vol. 32, Núm. 6, pp. 505-520

2001

  1. An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant

    Drug Metabolism and Disposition, Vol. 29, Núm. 5, pp. 712-720

1999

  1. Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways

    Biochemical Pharmacology, Vol. 58, Núm. 5, pp. 787-796